| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $7.1M | -72.5% |
| Cost of Revenue | $760K | -74.9% |
| R&D Expense | $91.0M | +78.3% |
| SG&A Expense | $29.8M | -18.8% |
| Operating Income | -$114.4M | -69.6% |
| Pre-tax Income | -$20.6M | +67.7% |
| Income Tax | $0 | — |
| Net Income | -$20.6M | +67.7% |
| EPS (Basic) | -$0.33 | +86.0% |
| EPS (Diluted) | -$0.33 | +86.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $37.6M | +31.0% |
| Short-term Investments | $108.1M | +482.4% |
| Accounts Receivable | $0 | -100.0% |
| Inventory | $0 | -100.0% |
| Current Assets | $149.0M | +143.1% |
| Total Assets | $150.8M | +114.5% |
| Current Liabilities | $14.5M | -15.0% |
| Total Liabilities |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$97.4M | -63.6% |
| Capital Expenditures | $552K | -66.6% |
| Investing Cash Flow | $11.9M | -52.8% |
| Financing Cash Flow | $94.4M | — |
| Free Cash Flow | -$98.0M | -60.1% |
| $14.5M |
| -18.6% |
| Stockholders' Equity | $136.3M | +159.7% |